ニューヨークにおける免疫系とその疾患の臨床試験
ニューヨーク内の拠点で、免疫系とその疾患に関する14件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07192471A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT06722235Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Hematology Oncology Associates of Central New York-Auburn, Auburn
- Roswell Park Cancer Institute, Buffalo
- Hematology Oncology Associates of CNY at Camillus, Camillus
- 他5件
被験者募集中観察研究
全年齢 · 全性別 · 2026/09/17更新 · NCT04242095A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06948318Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Roswell Park Comprehensive Cancer Center, Buffalo
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/25更新 · NCT05826535Abatacept for the Treatment of Giant Cell Arteritis
- Hospital for Special Surgery, New York
被験者募集中第3相
50歳以上 · 全性別 · 2026/08/20更新 · NCT04474847Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- NY Nephrology, Clifton Park
- Icahn School of Medicine at Mount Sinai, New York
被験者募集中第3相
18歳〜100歳 · 全性別 · 2026/08/17更新 · NCT06858319A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 6, Kew Gardens
- Inmagene Site 21, New York
- Inmagene Site 11, Woodbury
被験者募集中第2相
18歳〜74歳 · 全性別 · 2026/08/12更新 · NCT07037901Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT07216443A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
- Columbia University Irving Medical Center, New York
被験者募集中第2相
全年齢 · 全性別 · 2026/06/02更新 · NCT05787574A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- Columbia University, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/29更新 · NCT04422912CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Roswell Park Comprehensive Cancer Center, Buffalo
- Mt Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/16更新 · NCT03328078Biologics And Clinical Immunology Cohort at Sinai
- Mount Sinai, New York
被験者募集中観察研究
12歳以上 · 全性別 · 2026/02/17更新 · NCT04784364BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
- Sun River Health, Beacon
- Bedford Stuyvesant Family Health Center, Brooklyn
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/01/30更新 · NCT05341726ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。